Development of severe sclerotic chronic GVHD during treatment with dasatinib

被引：6

作者：

Pulanic, D. ^{[1
]}

Cowen, E. W. ^{[2
]}

Baird, K. ^{[3
]}

Bishop, M. R. ^{[1
]}

Pavletic, S. Z. ^{[1
]}

机构：

[1] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

[2] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

[3] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

来源：

BONE MARROW TRANSPLANTATION | 2010年 / 45卷 / 09期

关键词：

VERSUS-HOST-DISEASE; IMATINIB MESYLATE; EFFICACY; FIBROSIS;

D O I：

10.1038/bmt.2009.368

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：1469 / 1470

页数：2

共 10 条

[1]

Aguilera Dolly G, 2009, Ther Clin Risk Manag, V5, P281

[2] Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis [J].

Akhmetshina, Alfiya ;

Dees, Clara ;

Pileckyte, Margarita ;

Maurer, Britta ;

Axmann, Roland ;

Juengel, Astrid ;

Zwerina, Jochen ;

Gay, Steffen ;

Schett, Georg ;

Distler, Oliver ;

Distler, Joerg H. W. .

FASEB JOURNAL, 2008, 22 (07) :2214-2222

[3] Efficacy of dasatinib in a chronic myeloid leukemia patient with disease molecular relapse and chronic GVHD after haploidentical BMT: an immunomodulatory effect? [J].

Breccia, M. ;

Cannella, L. ;

Stefanizzi, C. ;

Carotti, A. ;

Santopietro, M. ;

Alimena, G. .

BONE MARROW TRANSPLANTATION, 2009, 44 (05) :331-332

[4] Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis [J].

Daniels, CE ;

Wilkes, MC ;

Edens, M ;

Kottom, TJ ;

Murphy, SJ ;

Limper, AH ;

Leof, EB .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (09) :1308-1316

[5] Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD [J].

Magro, L. ;

Catteau, B. ;

Coiteux, V. ;

Bruno, B. ;

Jouet, J-P ;

Yakoub-Agha, I. .

BONE MARROW TRANSPLANTATION, 2008, 42 (11) :757-760

[6] Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease [J].

Magro, Leonardo ;

Mohty, Mohamad ;

Catteau, Benoit ;

Coiteux, Valerie ;

Chevallier, Patrice ;

Terriou, Louis ;

Jouet, Jean-Pierre ;

Yakoub-Agha, Ibrahim .

BLOOD, 2009, 114 (03) :719-722

[7] Imatinib for refractory chronic graft-versus-host disease with fibrotic features [J].

Olivieri, Attilio ;

Locatelli, Franco ;

Zecca, Marco ;

Sanna, Adele ;

Cimminiello, Michele ;

Raimondi, Roberto ;

Gini, Guido ;

Mordini, Nicola ;

Balduzzi, Adriana ;

Leoni, Pietro ;

Gabrielli, Armando ;

Bacigalupo, Andrea .

BLOOD, 2009, 114 (03) :709-718

[8] Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation [J].

Schade, Andrew E. ;

Schieven, Gary L. ;

Townsend, Robert ;

Jankowska, Anna M. ;

Susulic, Vojkan ;

Zhang, Rosemary ;

Szpurka, Hadrian ;

Maciejewski, Jaroslaw P. .

BLOOD, 2008, 111 (03) :1366-1377

[9] Src kinases in systemic sclerosis [J].

Skhirtladze, Catherine ;

Distler, Oliver ;

Dees, Clara ;

Akhmetshina, Alfiya ;

Busch, Nicole ;

Venalis, Paulius ;

Zwerina, Jochen ;

Spriewald, Bernd ;

Pileckyte, Margarita ;

Schett, Georg ;

Distler, Joerg H. W. .

ARTHRITIS AND RHEUMATISM, 2008, 58 (05) :1475-1484

[10] Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease [J].

Stadler, Michael ;

Ahlborn, Renate ;

Kamal, Haytham ;

Diedrich, Helmut ;

Buchholz, Stefanie ;

Eder, Matthias ;

Ganser, Arnold .

BLOOD, 2009, 114 (17) :3718-3719

← 1 →